Analytical Considerations for Mass Spectrometry Profiling in Serum Biomarker Discovery

Gordon R. Whiteley, Simona Colantonio, Andrea Sacconi, Richard G. Saul

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The potential of using mass spectrometry profiling as a diagnostic tool has been demonstrated for a wide variety of diseases. Various cancers and cancer-related diseases have been the focus of much of this work because of both the paucity of good diagnostic markers and the knowledge that early diagnosis is the most powerful weapon in treating cancer. The implementation of mass spectrometry as a routine diagnostic tool has proved to be difficult, however, primarily because of the stringent controls that are required for the method to be reproducible. The method is evolving as a powerful guide to the discovery of biomarkers that could, in turn, be used either individually or in an array or panel of tests for early disease detection. Using proteomic patterns to guide biomarker discovery and the possibility of deployment in the clinical laboratory environment on current instrumentation or in a hybrid technology has the possibility of being the early diagnosis tool that is needed.

Original languageEnglish
Pages (from-to)57-69
Number of pages13
JournalClinics in Laboratory Medicine
Volume29
Issue number1
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Biomarkers
Mass spectrometry
Early Diagnosis
Mass Spectrometry
Serum
Clinical laboratories
Neoplasms
Weapons
Proteomics
Technology

Keywords

  • Bioinformatics
  • Biomarkers
  • Carrier proteins
  • Immune Capture
  • Low molecular weight proteome
  • MALDI
  • Proteomic patterns
  • Reproducibility

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry

Cite this

Analytical Considerations for Mass Spectrometry Profiling in Serum Biomarker Discovery. / Whiteley, Gordon R.; Colantonio, Simona; Sacconi, Andrea; Saul, Richard G.

In: Clinics in Laboratory Medicine, Vol. 29, No. 1, 03.2009, p. 57-69.

Research output: Contribution to journalArticle

Whiteley, Gordon R. ; Colantonio, Simona ; Sacconi, Andrea ; Saul, Richard G. / Analytical Considerations for Mass Spectrometry Profiling in Serum Biomarker Discovery. In: Clinics in Laboratory Medicine. 2009 ; Vol. 29, No. 1. pp. 57-69.
@article{0818731ca0c6471ab2631cca23b4e5f7,
title = "Analytical Considerations for Mass Spectrometry Profiling in Serum Biomarker Discovery",
abstract = "The potential of using mass spectrometry profiling as a diagnostic tool has been demonstrated for a wide variety of diseases. Various cancers and cancer-related diseases have been the focus of much of this work because of both the paucity of good diagnostic markers and the knowledge that early diagnosis is the most powerful weapon in treating cancer. The implementation of mass spectrometry as a routine diagnostic tool has proved to be difficult, however, primarily because of the stringent controls that are required for the method to be reproducible. The method is evolving as a powerful guide to the discovery of biomarkers that could, in turn, be used either individually or in an array or panel of tests for early disease detection. Using proteomic patterns to guide biomarker discovery and the possibility of deployment in the clinical laboratory environment on current instrumentation or in a hybrid technology has the possibility of being the early diagnosis tool that is needed.",
keywords = "Bioinformatics, Biomarkers, Carrier proteins, Immune Capture, Low molecular weight proteome, MALDI, Proteomic patterns, Reproducibility",
author = "Whiteley, {Gordon R.} and Simona Colantonio and Andrea Sacconi and Saul, {Richard G.}",
year = "2009",
month = "3",
doi = "10.1016/j.cll.2009.01.003",
language = "English",
volume = "29",
pages = "57--69",
journal = "Clinics in Laboratory Medicine",
issn = "0272-2712",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Analytical Considerations for Mass Spectrometry Profiling in Serum Biomarker Discovery

AU - Whiteley, Gordon R.

AU - Colantonio, Simona

AU - Sacconi, Andrea

AU - Saul, Richard G.

PY - 2009/3

Y1 - 2009/3

N2 - The potential of using mass spectrometry profiling as a diagnostic tool has been demonstrated for a wide variety of diseases. Various cancers and cancer-related diseases have been the focus of much of this work because of both the paucity of good diagnostic markers and the knowledge that early diagnosis is the most powerful weapon in treating cancer. The implementation of mass spectrometry as a routine diagnostic tool has proved to be difficult, however, primarily because of the stringent controls that are required for the method to be reproducible. The method is evolving as a powerful guide to the discovery of biomarkers that could, in turn, be used either individually or in an array or panel of tests for early disease detection. Using proteomic patterns to guide biomarker discovery and the possibility of deployment in the clinical laboratory environment on current instrumentation or in a hybrid technology has the possibility of being the early diagnosis tool that is needed.

AB - The potential of using mass spectrometry profiling as a diagnostic tool has been demonstrated for a wide variety of diseases. Various cancers and cancer-related diseases have been the focus of much of this work because of both the paucity of good diagnostic markers and the knowledge that early diagnosis is the most powerful weapon in treating cancer. The implementation of mass spectrometry as a routine diagnostic tool has proved to be difficult, however, primarily because of the stringent controls that are required for the method to be reproducible. The method is evolving as a powerful guide to the discovery of biomarkers that could, in turn, be used either individually or in an array or panel of tests for early disease detection. Using proteomic patterns to guide biomarker discovery and the possibility of deployment in the clinical laboratory environment on current instrumentation or in a hybrid technology has the possibility of being the early diagnosis tool that is needed.

KW - Bioinformatics

KW - Biomarkers

KW - Carrier proteins

KW - Immune Capture

KW - Low molecular weight proteome

KW - MALDI

KW - Proteomic patterns

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=64649086561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64649086561&partnerID=8YFLogxK

U2 - 10.1016/j.cll.2009.01.003

DO - 10.1016/j.cll.2009.01.003

M3 - Article

C2 - 19389551

AN - SCOPUS:64649086561

VL - 29

SP - 57

EP - 69

JO - Clinics in Laboratory Medicine

JF - Clinics in Laboratory Medicine

SN - 0272-2712

IS - 1

ER -